Fingolimod granted FDA Breakthrough Therapy designation for paediatric MS
Novartis today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for fingolimod for the treatment of children and adolescents 10 years of age or older with relapsing multiple sclerosis (MS)...Read more - http://www.ms-uk.org/fingolimod-granted ... diatric-ms
Fingolimod granted FDA Breakthrough Therapy designation...
Fingolimod granted FDA Breakthrough Therapy designation...
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2282 Views
-
Last post by frodo
-
- 0 Replies
- 10809 Views
-
Last post by NHE
-
- 2 Replies
- 1661 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1250 Views
-
Last post by NHE
-
- 2 Replies
- 1912 Views
-
Last post by frodo
-
- 0 Replies
- 11497 Views
-
Last post by NHE
-
- 0 Replies
- 2617 Views
-
Last post by frodo
-
- 0 Replies
- 2762 Views
-
Last post by NHE
-
- 1 Replies
- 1942 Views
-
Last post by frodo